Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.

A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.
This report contains market size and forecasts of Cardiac Rhythm Management (CRM) Devices in global, including the following market information:
Global Cardiac Rhythm Management (CRM) Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cardiac Rhythm Management (CRM) Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cardiac Rhythm Management (CRM) Devices companies in 2021 (%)
The global Cardiac Rhythm Management (CRM) Devices market was valued at 12470 million in 2021 and is projected to reach US$ 16750 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pacemaker Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cardiac Rhythm Management (CRM) Devices include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, Lepu (Qinming Medical), IMZ and Cardioelectronica and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cardiac Rhythm Management (CRM) Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac Rhythm Management (CRM) Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Rhythm Management (CRM) Devices Market Segment Percentages, by Type, 2021 (%)
Pacemaker
ICD
CRT
Global Cardiac Rhythm Management (CRM) Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Rhythm Management (CRM) Devices Market Segment Percentages, by Application, 2021 (%)
Bradycardia
Tachycardia
Heart Failure
Others
Global Cardiac Rhythm Management (CRM) Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Rhythm Management (CRM) Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiac Rhythm Management (CRM) Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cardiac Rhythm Management (CRM) Devices revenues share in global market, 2021 (%)
Key companies Cardiac Rhythm Management (CRM) Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cardiac Rhythm Management (CRM) Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Abbott
Boston Scientific
Biotronik
LivaNova (Sorin)
Medico
Lepu (Qinming Medical)
IMZ
Cardioelectronica
Pacetronix

LEAVE A REPLY

Please enter your comment!
Please enter your name here